T1	Participants 134 178	122 premenopausal women to receive tamoxifen
T2	Participants 221 239	54 evaluable women
T3	Participants 253 262	tamoxifen
T4	Participants 319 350	53 women having an oophorectomy
T5	Participants 573 584	58 patients
